Immunonutrition to improve immunotherapy in metastatic lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have metastatic non-small cell lung cancer confirmed by tissue testing (squamous or non-squamous types).
- You are starting first-line treatment for metastatic disease using immunotherapy (with or without chemotherapy).
- You can understand the study and agree by signing informed consent.
- You can take and continue oral supplement drinks/powders along with your immunotherapy (with or without chemotherapy).
- Your overall health ability score is 0–2 (better ability to do daily activities).
- You are expected to live at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes medical information (and sometimes tissue samples) to help personalize treatment plans for advanced non-small-cell lung cancer using immunotherapy. It may help researchers find which people benefit most and how treatment can be better matched to each patient.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
This trial studies whether adding special nutrition support (“immunonutrition”) can help people with head-and-neck cancer tolerate treatment with chemoradiotherapy, and possibly improve comfort and treatment completion. You may be eligible if you are starting or will have curative or extra (adjuvant) chemoradiotherapy and can complete study measurements.
This trial looks at how lung cancer and treatment affect your nutrition and metabolism. It aims to create a personalized nutrition plan for people with lung cancer.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
This trial tests whether adding nutrition support helps cancer patients with malnutrition respond better to immunotherapy. You may be able to join if you have cancer and are malnourished, are generally active, and can swallow pills.
Hear when a new Lung Cancer, Nonsmall Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.